Hakim, Joe B.
Painter, Jeffery L.
Ramcharran, Darmendra
Kara, Vijay
Powell, Greg
Sobczak, Paulina
Sato, Chiho
Bate, Andrew
Beam, Andrew
Funding for this research was provided by:
GlaxoSmithKline Biologicals S.A.
Article History
Received: 29 May 2025
Accepted: 25 June 2025
First Online: 31 July 2025
Declarations
:
: All GSK co-authors (Jeffery L Painter, Darmendra Ramcharran, Vijay Kara, Greg Powell, Paulina Sobczak, Chiho Sato, Andrew Bate) receive GSK salary and some hold GSK stock and stock options. Andrew L Beam is a consultant for Generate Biomedicines and Flagship Pioneering, Inc and holds stock and stock options in Generate Biomedicines and FL 85, Inc. The rest of the co-authors (Joe B. Hakim) have no conflict of interest to state.